Author:
Gozashti Mohammad Hossein,Hasanzadeh Ali,Mashrouteh Mahdieh
Abstract
Abstract
Background
Atherosclerotic disorders, hypertension and lipid profile alterations are of a lower prevalence in patients with minor beta thalassemia. On the other hand, nowadays, metabolic syndrome is considered as one of the major risk factors of developing cardiovascular diseases. Therefore, the present study was performed to determine the prevalence of metabolic syndrome in patients with minor beta thalassemia.
Methods
In this case-control study, body length, weight and waist circumference, blood pressure, fasting blood sugar [FBS], triglyceride, cholesterol, HDL, and LDL levels were determined in 150 patients with minor beta thalassemia and 300 healthy individuals as control group [matched based on age and sex]. The prevalence of metabolic syndrome was calculated based on ATPIII criteria. Data were analyzed through SPSS16 software package.
Results
The prevalence of metabolic syndrome was 12.7% in the thalassemia group and 36.7% in the control group [p < 0.0001]. In the patient group, 3 ones [8.3%] of those with metabolic syndrome were male and 16 ones [14%] were female [p = 0.5]. Mean age of patients with metabolic syndrome was 39.4 ± 8.5 years and mean age of those without metabolic syndrome was 36.4 ± 7.8 years [p = 0.1]. Mean BMI of those with metabolic syndrome was 31.3 ± 4.1 kg/m2 and that of those without metabolic syndrome was 24.2 ± 4.4 kg/m2 [p < 0.0001].
Conclusions
The obtained results show lower prevalence of metabolic syndrome in patients with minor thalassemia. Moreover, the prevalence of metabolic syndrome in patients with minor thalassemia showed no relationship with sex and age and these patients had just higher BMI.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference29 articles.
1. Larsen K, Melmed P: Williams Textbook of Endocrinology. 10th edition. 2003.
2. Defronzo RA, Ferrannini E: Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991, 14: 173. 10.2337/diacare.14.3.173
3. Koh KK, Han SH, Quou MJ: Inflammatory markers and the metabolic syndrome insighst from therapeutic interventions. J Am CollCardiol 2005, 46: 1978. 10.1016/j.jacc.2005.06.082
4. Lindsay RS, Howard BV: Cardiovascular risk associated with the metabolic syndrome. CurrDiab Rep 2004, 4: 63.
5. Reaven GM: Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988, 37: 159. 10.2337/diab.37.1.28
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献